About CHARMACY PHAR Company

Chuangmei Pharmaceutical Co., Ltd. (stock code: 2289.HK) is mainly engaged in pharmaceutical distribution business. It mainly distributes Western medicines, proprietary Chinese medicines, health products and other products to downstream distributors and retail terminals. It also provides third-party logistics services and pharmaceutical product consulting services. The company was founded in 2000, and after 24 years of rapid development, it has grown into one of the leading pharmaceutical distributors in South China. The company adheres to the development strategy of “deeply cultivating Guangdong and radiating the surrounding area”. It is based in Shantou, and has established subsidiaries in Guangzhou, Zhuhai, Huizhou, Foshan and Shenzhen, and has four modern pharmaceutical logistics centers, professional marketing service teams and transportation service teams to implement an efficient distribution mechanism of “three deliveries a day within a radius of 10 km, two deliveries a day within 50 km, and one delivery per day within 250 km” for non-tendered markets. The company has a modern information system covering the entire pharmaceutical distribution supply chain, including procurement, sales, warehousing, transportation and delivery. The company also operates a self-built B2B e-commerce platform: “Chuangmei e-Medicine”, which allows customers to place orders, inquire and pay online. The company ranked 38 in the top 100 for the main business revenue of wholesale enterprises in the country in 2022. The company ranked 6th among pharmaceutical distribution companies in Guangdong Province. In 2023, relying on an excellent warehousing and distribution system, the Group obtained the 2023-2023 Pharmaceutical Logistics Excellent Enterprise (obtained for 3 consecutive years), the 2023-2023 Modern Pharmaceutical Logistics Technology Test Base (Center) (obtained for 2 consecutive years), the 2023-2023 Pharmaceutical Cold Chain Best Logistics Center (base) (obtained for 5 consecutive years), the 2023-2023 Pharmaceutical Cold Chain Logistics Service Recommended Enterprise (obtained for 4 consecutive years), and the 2023-2023 Pharmaceutical Tripartite Modern Logistics Service Capability The top 50 smart pharmaceutical supply chain integrated service outstanding case awards won the 2022 China Pharmaceutical Supply Chain Focus Enterprise by the Pharmaceutical Logistics Branch of the China Federation of Logistics and Purchasing, the top ten logistics centers in the 2023-2023 year, and the 2021-2023 China Logistics Industry Golden Ant Innovation Award issued by the China (Guangzhou) International Logistics Equipment and Technology Exhibition Organizing Committee (for 6 consecutive years). Thanks to its good reputation and excellent service, the company was awarded the top 100 pharmaceutical business enterprises in China in 2022 and 2023 by the Pharmaceutical Chamber of Commerce of the All-China Federation of Industry and Commerce, and won the 4th Pharmaceutical Goldstone Award and the 2023 Best Pharmaceutical Marketing Team Award from Cyberblue.